Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at (...)
Site référencé: The Economic Times
The Economic Times
Buffett says US shouldn't use "trade as a weapon" as Trump has done with tariffs
3/05/2025
Berkshire endorses Japanese trading houses, could hold them 'forever'
3/05/2025
Buffett says US shouldn't use "trade as a weapon" as Trump has done with tariffs
3/05/2025
Buffett takes the stage at Berkshire Hathaway meeting
3/05/2025
DMart Q4 results : Standalone PAT jumps 2% YoY, revenue surges 17%
3/05/2025
Berkshire shareholders head to Buffett's 60th annual meeting, economy top of mind
3/05/2025
